Literature DB >> 8227196

Alpha melanocyte stimulating hormone (alpha MSH) stimulates normal human melanocyte growth by binding to high-affinity receptors.

M De Luca1, W Siegrist, S Bondanza, M Mathor, R Cancedda, A N Eberle.   

Abstract

The combined action of cholera toxin (CT)-dependent activation of the adenylate cyclase signaling pathway, stimulation of protein kinase C, and activation of the tyrosine kinase activity of cell surface receptors and proto-oncogene products, have been shown to stimulate melanocyte proliferation. However, natural factors responsible for the optimal stimulation of normal human melanocyte growth, either isolated or co-cultured with keratinocytes, remain largely unknown. alpha MSH (alpha melanocyte stimulating hormone) has previously been shown to bind to murine and human melanoma cells and to stimulate their adenylate cyclase and tyrosinase activity. In contrast, very little is known about the presence and function of alpha MSH receptors in normal human melanocytes. We now report that alpha MSH: (i) binds to normal human melanocytes through a single class of high-affinity receptors; (ii) does not induce per se melanocytes to enter the S-phase of the cell cycle; (iii) does indeed stimulate melanocyte proliferation in a dose-dependent fashion; but its stimulatory effect requires bFGF and/or the activation of protein kinase C.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227196     DOI: 10.1242/jcs.105.4.1079

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  18 in total

Review 1.  Pigmented human skin equivalent--as a model of the mechanisms of control of cell-cell and cell-matrix interactions.

Authors:  K Nakazawa; M Kalassy; F Sahuc; C Collombel; O Damour
Journal:  Med Biol Eng Comput       Date:  1998-11       Impact factor: 2.602

2.  The potential role of vitamin D in the progression of benign and malignant melanocytic neoplasms.

Authors:  Joel Pinczewski; Andrzej Slominski
Journal:  Exp Dermatol       Date:  2010-10       Impact factor: 3.960

3.  Dissecting Wnt Signaling for Melanocyte Regulation during Wound Healing.

Authors:  Qi Sun; Piul Rabbani; Makoto Takeo; Soung-Hoon Lee; Chae Ho Lim; En-Nekema Shandi Noel; M Mark Taketo; Peggy Myung; Sarah Millar; Mayumi Ito
Journal:  J Invest Dermatol       Date:  2018-02-08       Impact factor: 8.551

4.  DNA damage enhances melanogenesis.

Authors:  M S Eller; K Ostrom; B A Gilchrest
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

5.  Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair.

Authors:  M T Bastiaens; J A ter Huurne; C Kielich; N A Gruis; R G Westendorp; B J Vermeer; J N Bavinck
Journal:  Am J Hum Genet       Date:  2001-03-16       Impact factor: 11.025

6.  MC1R and cAMP signaling inhibit cdc25B activity and delay cell cycle progression in melanoma cells.

Authors:  Jesse Lyons; Boris C Bastian; Frank McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-01       Impact factor: 11.205

7.  Binding of alpha-melanocyte-stimulating hormone to its G-protein-coupled receptor on B-lymphocytes activates the Jak/STAT pathway.

Authors:  J J Buggy
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

8.  Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides.

Authors:  Z Abdel-Malek; V B Swope; I Suzuki; C Akcali; M D Harriger; S T Boyce; K Urabe; V J Hearing
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

Review 9.  Proopiomelanocortin production by epidermal cells: evidence for an immune neuroendocrine network in the epidermis.

Authors:  R S Bhardwaj; T A Luger
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

Review 10.  Skin as a living coloring book: how epithelial cells create patterns of pigmentation.

Authors:  Lorin Weiner; Wenyu Fu; William J Chirico; Janice L Brissette
Journal:  Pigment Cell Melanoma Res       Date:  2014-09-01       Impact factor: 4.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.